Beta Research Development from 2010 to 2025
| BBNX Stock | 31.22 0.64 2.01% |
Research Development | First Reported 2010-12-31 | Previous Quarter 26.2 M | Current Value 20.1 M | Quarterly Volatility 4.3 M |
Check Beta Bionics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beta Bionics,'s main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 2.2 M or Depreciation And Amortization of 992.5 K, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0 or PTB Ratio of 1.88. Beta financial statements analysis is a perfect complement when working with Beta Bionics, Valuation or Volatility modules.
Check out the analysis of Beta Bionics, Correlation against competitors. Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Beta Stock Analysis
When running Beta Bionics,'s price analysis, check to measure Beta Bionics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Bionics, is operating at the current time. Most of Beta Bionics,'s value examination focuses on studying past and present price action to predict the probability of Beta Bionics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Bionics,'s price. Additionally, you may evaluate how the addition of Beta Bionics, to your portfolios can decrease your overall portfolio volatility.